Kestra Medical Technologies Ltd. (KMTS)
27.18
+0.36
(+1.34%)
USD |
NASDAQ |
Dec 18, 16:00
27.18
0.00 (0.00%)
After-Hours: 18:16
Kestra Medical Technologies Research and Development Expense (Annual): 15.65M for April 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Bruker Corp. | 376.50M |
| Azenta, Inc. | 30.39M |
| Harvard Bioscience, Inc. | 10.41M |
| Phibro Animal Health Corp. | 23.73M |
| Bionano Genomics, Inc. | 24.80M |